Chinese biotech startup MediLink Therapeutics has raised 350 million yuan ($54.2 million) in a Series A round, while Chinese buyout firm Lunar Capital has agreed to purchase a 64.85% stake in a women’s health and in vitro fertilisation (IVF) business in Hong Kong.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
